摘要
目的观察地榆升白片在放疗所致白细胞下降中的治疗作用。方法90例放疗过程中出现骨髓抑制的恶性肿瘤病人随机分为3组,实验组地榆升白片+重组人粒细胞集落刺激因子(G-CSF);对照1组利血生+G-CSF;对照2组单独使用G-CSF,治疗放疗所致骨髓抑制,比较其疗效及观察病人一般状态改善情况。结果实验组疗效明显高于对照组,病人一般状态改善情况优于对照组。结论地榆升白片治疗放疗所致的白细胞下降,疗效明显,能改善病人的一般状态,且无明显毒副作用,价格低廉,可作为放化疗骨髓抑制时的常规口服用药。
Objective： To evaluate the effect of sanguisorba leucocyte increasing tablet on leukopenia induced by radiotherapy. Methods： Ninety malignant tumor patients with myelosuppression during radiotherapy were randomized into three groups to be compared the efficacy and the improvement of performance status when they were respectively treated with ： the test group ： sanguisorba leucocyte increasing tablets ＋ G - CSF ; control group ①： leucogen tablets ＋ G - CSF; control group ②： only G - CSF. Results： The effect of the test group was significantly better than that of the control groups. And the test group was also superior in the improvement of patients status. Conclusion： Sanguisorba leucocyte increasing tablet is an effective treatment with favorable cost for the patients with myelosuppression during radiotherapy. There is no significant toxic effect.
出处
《现代肿瘤医学》
CAS
2007年第2期264-266,共3页
Journal of Modern Oncology
关键词
恶性肿瘤
地榆升白片
放射疗法
malignant tumor
sanguisorba leucocyte increasing tablets
radiotherapy
